Charles River Associates publishes CRA Insights, a newsletter highlighting recent thinking and announcements from members of our Life Sciences Practice.
Drug pricing rules and tariffs reshape transfer pricing for IP
In the article “Drug Pricing Rules and Tariffs Reshape Transfer Pricing for IP,” published in Bloomberg Tax, CRA’s Transfer Pricing experts Robin Hart and ...